Literature DB >> 26645547

Vagus nerve stimulation inhibits cortical spreading depression.

Shih-Pin Chen1, Ilknur Ay, Andreia Lopes de Morais, Tao Qin, Yi Zheng, Homa Sadeghian, Fumiaki Oka, Bruce Simon, Katharina Eikermann-Haerter, Cenk Ayata.   

Abstract

Vagus nerve stimulation has recently been reported to improve symptoms of migraine. Cortical spreading depression is the electrophysiological event underlying migraine aura and is a trigger for headache. We tested whether vagus nerve stimulation inhibits cortical spreading depression to explain its antimigraine effect. Unilateral vagus nerve stimulation was delivered either noninvasively through the skin or directly by electrodes placed around the nerve. Systemic physiology was monitored throughout the study. Both noninvasive transcutaneous and invasive direct vagus nerve stimulations significantly suppressed spreading depression susceptibility in the occipital cortex in rats. The electrical stimulation threshold to evoke a spreading depression was elevated by more than 2-fold, the frequency of spreading depressions during continuous topical 1 M KCl was reduced by ∼40%, and propagation speed of spreading depression was reduced by ∼15%. This effect developed within 30 minutes after vagus nerve stimulation and persisted for more than 3 hours. Noninvasive transcutaneous vagus nerve stimulation was as efficacious as direct invasive vagus nerve stimulation, and the efficacy did not differ between the ipsilateral and contralateral hemispheres. Our findings provide a potential mechanism by which vagus nerve stimulation may be efficacious in migraine and suggest that susceptibility to spreading depression is a suitable platform to optimize its efficacy.

Entities:  

Mesh:

Year:  2016        PMID: 26645547      PMCID: PMC4943574          DOI: 10.1097/j.pain.0000000000000437

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  64 in total

1.  Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice.

Authors:  Katharina Eikermann-Haerter; Izumi Yuzawa; Tao Qin; Yumei Wang; Kwangyeol Baek; Young Ro Kim; Ulrike Hoffmann; Ergin Dilekoz; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

2.  Can vagus nerve stimulation help migraine?

Authors:  M E Lenaerts; K J Oommen; J R Couch; V Skaggs
Journal:  Cephalalgia       Date:  2008-02-14       Impact factor: 6.292

3.  Vasoconstrictive neurovascular coupling during focal ischemic depolarizations.

Authors:  Hwa Kyoung Shin; Andrew K Dunn; Phillip B Jones; David A Boas; Michael A Moskowitz; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2005-12-07       Impact factor: 6.200

4.  Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura.

Authors:  Xichun Zhang; Dan Levy; Rodrigo Noseda; Vanessa Kainz; Moshe Jakubowski; Rami Burstein
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

5.  Serotonin depletion leads to cortical hyperexcitability and trigeminal nociceptive facilitation via the nitric oxide pathway.

Authors:  Supang Maneesri le Grand; Weera Supornsilpchai; Chonlawan Saengjaroentham; Anan Srikiatkhachorn
Journal:  Headache       Date:  2011-06-07       Impact factor: 5.887

6.  Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius.

Authors:  B R Walker; A Easton; K Gale
Journal:  Epilepsia       Date:  1999-08       Impact factor: 5.864

7.  Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems.

Authors:  Stella Manta; Mostafa El Mansari; Guy Debonnel; Pierre Blier
Journal:  Int J Neuropsychopharmacol       Date:  2012-04-17       Impact factor: 5.176

8.  Suppression of cortical spreading depression in migraine prophylaxis.

Authors:  Cenk Ayata; Hongwei Jin; Chiho Kudo; Turgay Dalkara; Michael A Moskowitz
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

9.  Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia.

Authors:  Ilknur Ay; Jie Lu; Hakan Ay; A Gregory Sorensen
Journal:  Neurosci Lett       Date:  2009-05-13       Impact factor: 3.046

10.  Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures.

Authors:  E Ben-Menachem; A Hamberger; T Hedner; E J Hammond; B M Uthman; J Slater; T Treig; H Stefan; R E Ramsay; J F Wernicke
Journal:  Epilepsy Res       Date:  1995-03       Impact factor: 3.045

View more
  41 in total

1.  Noninvasive Vagus Nerve Stimulation Prevents Ruptures and Improves Outcomes in a Model of Intracranial Aneurysm in Mice.

Authors:  Tomoaki Suzuki; Tsubasa Takizawa; Yoshinobu Kamio; Tao Qin; Tomoki Hashimoto; Yukihiko Fujii; Yuichi Murayama; Aman B Patel; Cenk Ayata
Journal:  Stroke       Date:  2019-05       Impact factor: 7.914

Review 2.  Neurostimulation methods in the treatment of chronic pain.

Authors:  X Moisset; M Lanteri-Minet; D Fontaine
Journal:  J Neural Transm (Vienna)       Date:  2019-10-21       Impact factor: 3.575

3.  L-PGDS Mediates Vagus Nerve Stimulation-Induced Neuroprotection in a Rat Model of Ischemic Stroke by Suppressing the Apoptotic Response.

Authors:  Lina Zhang; Jingxi Ma; Xinhao Jin; Gongwei Jia; Ying Jiang; Changqing Li
Journal:  Neurochem Res       Date:  2016-11-29       Impact factor: 3.996

4.  Systematic review of the pharmacological agents that have been tested against spreading depolarizations.

Authors:  Anna Klass; Renan Sánchez-Porras; Edgar Santos
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-20       Impact factor: 6.200

Review 5.  A Short Review of the Non-invasive Transcutaneous Pericranial Electrical Stimulation Techniques and their Application in Headache.

Authors:  Licia Grazzi; Emanuela Sansone; Paul Rizzoli
Journal:  Curr Pain Headache Rep       Date:  2018-01-19

6.  Timing Considerations for Noninvasive Vagal Nerve Stimulation in Clinical Studies.

Authors:  Nil Z Gurel; Asim H Gazi; Kristine L Scott; Matthew T Wittbrodt; Amit J Shah; Viola Vaccarino; J Douglas Bremner; Omer T Inan
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

7.  Modulation of brainstem activity and connectivity by respiratory-gated auricular vagal afferent nerve stimulation in migraine patients.

Authors:  Ronald G Garcia; Richard L Lin; Jeungchan Lee; Jieun Kim; Riccardo Barbieri; Roberta Sclocco; Ajay D Wasan; Robert R Edwards; Bruce R Rosen; Nouchine Hadjikhani; Vitaly Napadow
Journal:  Pain       Date:  2017-08       Impact factor: 6.961

Review 8.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

9.  Automatic Detection of Target Engagement in Transcutaneous Cervical Vagal Nerve Stimulation for Traumatic Stress Triggers.

Authors:  Nil Z Gurel; Matthew T Wittbrodt; Hewon Jung; Stacy L Ladd; Amit J Shah; Viola Vaccarino; J Douglas Bremner; Omer T Inan
Journal:  IEEE J Biomed Health Inform       Date:  2020-03-16       Impact factor: 5.772

Review 10.  Emerging Treatments in Episodic Migraine.

Authors:  Kate W Grimsrud; Rashmi B Halker Singh
Journal:  Curr Pain Headache Rep       Date:  2018-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.